Is this your brand? Sign in to claim ownership.
Sign in to claim this brandBayer Medical Care Inc.
United States·US-MF-000007050
Last updated September 17, 2026
What Bayer Medical Care Inc. makes
The company manufactures disposable and reusable components for contrast medium injection, including angiographic syringes, radiographic tubing, and mobile injection systems for CT and angiography procedures. It also produces MRI-specific radio-frequency coils and battery-powered contrast injection systems, alongside hand controller kits and general-purpose fluid transfer sets. Devices like the MEDRAD® Vflow Hand Controller and Stellant CT Injection System are designed for precise contrast delivery in diagnostic imaging.
The portfolio includes devices classified as Class I, Class II, Class IIa, and Class IIb under global regulatory frameworks. Products are listed in the EU’s eudamed registry and the FDA’s Unique Device Identifier (UDI) database. The company operates from the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Bayer Medical Care Inc. manufacture?
Bayer Medical Care Inc. specializes in disposable and reusable medical devices primarily used in diagnostic imaging. Their portfolio includes angiographic syringes, radiographic procedure tubing, mobile contrast medium injection systems for CT and angiography, MRI-specific radio-frequency coils, battery-powered contrast injection systems, hand controller kits, and general-purpose fluid transfer sets. These devices are designed to support precise contrast medium delivery and fluid management in procedures like CT scans, angiography, and MRI.
Where is Bayer Medical Care Inc. based, and how does that affect its regulatory standing?
Bayer Medical Care Inc. is based in the United States. As a U.S.-based manufacturer, its devices are subject to FDA regulations, including the requirement for listing in the FDA’s Unique Device Identifier (UDI) database. Additionally, some of its devices are listed in the EU’s eudamed registry, indicating their availability or registration in the European market under applicable EU medical device regulations.
Which regulatory registries list Bayer Medical Care Inc.’s devices, and why is this important?
Bayer Medical Care Inc.’s devices are listed in two key regulatory registries: the EU’s eudamed and the FDA’s Unique Device Identifier (UDI) database. Listing in eudamed ensures visibility and traceability of devices marketed in the European Economic Area, while inclusion in the FDA’s UDI database facilitates regulatory oversight, post-market surveillance, and transparency in the U.S. market. These registries help healthcare providers, regulators, and patients access critical information about the devices’ identification, classification, and compliance status.
How are Bayer Medical Care Inc.’s devices classified under global regulatory frameworks?
Bayer Medical Care Inc.’s devices are classified under various risk-based categories, including Class I, Class II, Class IIa, and Class IIb. Classification determines the regulatory controls applied to ensure safety and performance. For example, Class IIb devices typically involve higher risks and require more stringent pre-market evaluations, such as clinical data or special controls, compared to Class I devices, which generally pose minimal risk. The classification ensures that devices are assessed proportionally to their potential impact on patient safety.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- United States
- Address
- 1, Bayer Drive, Indianola, United States
- Website
- bayer.com
- —
- —
- [email protected]
- Phone
- —
- PRRC Contact
- Joseph Kridgen
- EUDAMED SRN
- US-MF-000007050
- FDA FEI Number
- 2520313
- DUNS Number
- —
Catalogue (467)
Page 2 of 10Related Companies
Authorised Representatives
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (9)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
Bayer Medical Care Inc. has nine FDA recall records initiated between June 28, 2018, and April 24, 2026. The records include open, classified, and terminated statuses, with reasons involving potential product defects such as black specks in needles, leaks in syringe kits, loose particulate from dust caps, labeling errors, mechanical disengagement risks in injector systems, and issues related to torque specifications on ceiling column assemblies. Supplier changes and fit problems with contrast flow control valves were also cited as contributing factors in some cases.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Apr 24, 2026 | Z-2296-2026 | — | open, classified | Supplier changes resulted in a fit issue with the Contrast Flow Control Valve (CFCV) interface on the Avanta Injector System. Multiple customer reports indicate that the stopcock cannot be reliably engaged with the CFCV snap interface. In instances where engagement is achieved through applied force, the connection is unstable, and the stopcock may disengage before or during contrast injection, leading to procedure interruption. |
| Nov 30, 2022 | Z-0910-2023 | — | open, classified | Black specks may be present on the packaged needles |
| Sep 14, 2021 | Z-0199-2022 | — | terminated | Labeling error: MEDRAD Mark 7 Arterion Injection System Syringes (ART 700 SYR) labeled as Twist & Go Syringes (TAG 150 SYR) |
| Oct 5, 2020 | Z-0483-2021 | — | terminated | Specific lots of MEDRAD Stellant FLEX 150 mL syringe kits may have holes and/or cracks that have the potential to allow fluid to leak out of the syringe. |
| Dec 14, 2018 | Z-0745-2019 | — | terminated | If the head mount knob is not properly tightened and the operator directly uses the injector head to move the unit, it may become disengaged, causing the injector head to become loose or fall. |
| Sep 7, 2018 | Z-0097-2019 | — | terminated | Bayer has received reports of loose particulate in the filter when the dust cap is removed. Bayer conducted further testing confirming the dust cap may generate particulate which may potentially enter the fluid path. |
| Jun 28, 2018 | Z-2960-2018 | — | terminated | The torque wrench used on the ceiling column assembly during a recent service visit was outside of the torque specification, potentially overtightening the bolts. The overtightening of bolts may compromise the structural integrity of the system which could lead to the OCS disengaging from the ceiling mount and this may cause injury to the patient or the operator. |
| Jun 28, 2018 | Z-2961-2018 | — | terminated | The torque wrench used on the ceiling column assembly during a recent service visit was outside of the torque specification, potentially overtightening the bolts. The overtightening of bolts may compromise the structural integrity of the system which could lead to the OCS disengaging from the ceiling mount and this may cause injury to the patient or the operator. |
| Jun 28, 2018 | Z-2962-2018 | — | terminated | The torque wrench used on the ceiling column assembly during a recent service visit was outside of the torque specification, potentially overtightening the bolts. The overtightening of bolts may compromise the structural integrity of the system which could lead to the OCS disengaging from the ceiling mount and this may cause injury to the patient or the operator. |